Cathay Genl Bncp (CATY) 29.12 $CATY Cathay General

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cathay Genl Bncp (CATY) 29.12 $CATY

Cathay General Bancorp Announces Agreement To Acquire SinoPac Bancorp
PR Newswire - Fri Jul 08, 8:00AM CDT
Cathay General Bancorp ("Cathay", NASDAQ: CATY) and Bank SinoPac Co. Ltd. ("Bank SinoPac" today announced that they have signed a Stock Purchase Agreement for Cathay to acquire SinoPac Bancorp, the U.S. subsidiary of Bank SinoPac, for $340 million subject to certain adjustments.
CATY: 29.12 (+0.42)

Cathay General Bancorp to Announce Second Quarter 2016 Financial Results
GlobeNewswire - Thu Jul 07, 3:30PM CDT
Cathay General Bancorp (NASDAQ:CATY), the holding company for Cathay Bank, is scheduled to announce its second quarter 2016 financial results after the markets close on Wednesday, July 20, 2016.
CATY: 29.12 (+0.42)

Financial Sector Equities Coverage -- Mitsubishi UFJ Financial Group, TCF Financial, Sterling Bancorp., and Cathay General Bancorp.
PR Newswire - Thu Jun 30, 6:45AM CDT
On Wednesday, June 29, 2016, the NASDAQ Composite ended the trading session at 4,779.25, up 1.86%; the Dow Jones Industrial Average advanced 1.64%, to finish at 17,694.68; and the S&P 500 closed at 2,070.77, up 1.70%. The gains were broad based as all the sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Mitsubishi UFJ Financial Group Inc. (NYSE: MTU), TCF Financial Corporation (NYSE: TCB), Sterling Bancorp. (NYSE: STL), and Cathay General Bancorp. (NASDAQ: CATY). Learn more about these stocks by accessing their free trade alerts at:
MTU: 4.44 (+0.10), CATY: 29.12 (+0.42), STL: 16.17 (+0.28), TCB: 12.53 (+0.09)

BlackRock Buys 50% Stake in Texas Wind Project from GE
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:17AM CDT
A unit of BlackRock, Inc. (BLK) has inked a deal to acquire 50% interest in the Grandview wind project from GE Energy Financial Services, a division of General Electric Company (GE)
GE: 32.21 (+0.01), BLK: 347.50 (+2.30), CATY: 29.12 (+0.42), FBP: 4.28 (+0.11)

Will PNC Financial Continue to Face Revenue Pressure?
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:04AM CDT
The PNC Financial Services Group, Inc. (PNC) is facing revenue pressure amid an overall challenging environment
CATY: 29.12 (+0.42), FBP: 4.28 (+0.11), PNC: 81.06 (+0.44), LPLA: 23.08 (+0.37)

Goldman Sachs (GS) Expands Consumer Banking Business
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 4:32PM CDT
The Goldman Sachs Group, Inc. (GS), widely focused on large companies and wealthy clients, is expanding its offerings to general consumers through its new retail banking service.
GS: 152.19 (+1.81), CATY: 29.12 (+0.42), FBP: 4.28 (+0.11), LPLA: 23.08 (+0.37)

Goldman's Tussle with Libyan Fund Escalates as Trial Begins
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:34AM CDT
In the trial which began on Monday , The Goldman Sachs Group, Inc. (GS) was accused by Libyan Investment Authority of exploiting its relationship with the fund to make risky and worthless derivative trades.
GS: 152.19 (+1.81), CATY: 29.12 (+0.42), FBP: 4.28 (+0.11), LPLA: 23.08 (+0.37)

Cathay General Bancorp Declares $0.18 Per Share Dividend
PR Newswire - Thu May 19, 7:30PM CDT
Cathay General Bancorp (NASDAQ: CATY), the holding company for Cathay Bank, announced today that its Board of Directors declared a cash dividend of eighteen cents per common share, payable on June 13, 2016, to stockholders of record at the close of business on June 1, 2016.
CATY: 29.12 (+0.42)

New Strong Buy Stocks for May 17th
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:18AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
STCK: 19.26 (-0.39), AGR: 45.87 (-0.01), CATY: 29.12 (+0.42), CP: 133.01 (-0.34), Y: 548.03 (+0.47)

Cathay posts 1Q profit
Automated Insights - Wed Apr 20, 4:03PM CDT
LOS ANGELES (AP) _ Cathay General Bancorp (CATY) on Wednesday reported first-quarter net income of $46.2 million.
CATY: 29.12 (+0.42)

Cathay General Bancorp Announces First Quarter 2016 Results
PR Newswire - Wed Apr 20, 3:30PM CDT
Cathay General Bancorp (the "Company", NASDAQ: CATY), the holding company for Cathay Bank, today announced net income of $46.2 million, or $0.57 per share, for the first quarter of 2016.
CATY: 29.12 (+0.42)

Cathay Bank Announces the Appointment of Mr. Kelly Wu as Executive Vice President, Corporate Banking Division
PR Newswire - Tue Apr 12, 4:55PM CDT
Cathay Bank announces the appointment of Mr. Kelly Wu as Executive Vice President, Corporate Banking Division.
CATY: 29.12 (+0.42)

Cathay General Bancorp adopts new share repurchase program
M2 - Tue Feb 09, 10:50AM CST
Board of directors of Cathay General Bancorp (NASDAQ: CATY) has adopted a new stock repurchase program authorizing the company to repurchase up to USD45,000,000 of the company's common stock, the company said. On August 31, 2015, the company adopted a stock repurchase program under which it was authorized to repurchase up to two million shares of its common stock, all of which have since been repurchased. Cathay General Bancorp is the holding company for Cathay Bank, a California state-chartered bank. Founded in 1962, Cathay Bank offers a wide range of financial services, and currently operates in California, New York State, Chicago, Washington State, Texas, Maryland, Massachusetts, n Nevada, New Jersey, Hong Kong, Taipei and in Shanghai.
CATY: 29.12 (+0.42)

Cathay General Bancorp Has Returned 15.1% Since SmarTrend Recommendation (CATY)
Comtex SmarTrend(R) - Tue Feb 02, 3:48PM CST
SmarTrend identified a Downtrend for Cathay General Bancorp (NASDAQ:CATY) on December 9th, 2015 at $32.06. In approximately 2 months, Cathay General Bancorp has returned 15.13% as of today's recent price of $27.21.
CATY: 29.12 (+0.42)

Cathay General Bancorp Adopts New Share Repurchase Program
PR Newswire - Mon Feb 01, 5:07PM CST
Cathay General Bancorp (the "Company", (NASDAQ: CATY), the holding company for Cathay Bank, announced today that its Board of Directors has adopted a new stock repurchase program authorizing the Company to repurchase up to $45,000,000 of the Company's common stock. Any purchases under the new program will be made from time to time in the open market. The timing and amount of any stock repurchases will be determined by the Company's management based on its evaluation of market conditions, regulatory requirements and other factors.
CATY: 29.12 (+0.42)

Fitch Affirms Synovus at 'BBB-' Following Midtier Regional Bank Review; Outlook Stable
BusinessWire - Thu Jan 28, 2:05PM CST
Fitch Ratings has affirmed Synovus Financial Corp. (SNV) ratings at 'BBB-/F3'. The Rating Outlook remains Stable.
EWBC: 34.20 (+0.66), BOKF: 61.80 (+0.68), UMBF: 54.21 (+0.75), SNV: 28.98 (+0.42), CATY: 29.12 (+0.42), TCB: 12.53 (+0.09), TRMK: 25.16 (+0.47), FULT: 13.74 (+0.25), BKU: 30.87 (+0.51), FHN: 13.98 (+0.19)

Fitch Affirms Fulton Financial's Ratings at 'BBB+/F2'; Outlook Stable
BusinessWire - Thu Jan 28, 2:01PM CST
Fitch Ratings has affirmed Fulton Financial Corp. (FULT) ratings at 'BBB+/F2'. The Rating Outlook remains Stable. The affirmation reflects FULT's strong asset quality, solid capital and an established franchise.
EWBC: 34.20 (+0.66), BOKF: 61.80 (+0.68), UMBF: 54.21 (+0.75), SNV: 28.98 (+0.42), CATY: 29.12 (+0.42), TCB: 12.53 (+0.09), TRMK: 25.16 (+0.47), FULT: 13.74 (+0.25), BKU: 30.87 (+0.51), FHN: 13.98 (+0.19)

Fitch Affirms BankUnited, Inc.'s 'BBB/F2' IDRs; Outlook Stable
BusinessWire - Thu Jan 28, 2:00PM CST
Fitch Ratings has affirmed the Long-term Issuer Default Ratings (IDRs) at 'BBB' and Short-term IDRs at 'F2' for BankUnited, Inc. (BankUnited) and BankUnited, N.A. The Rating Outlook is Stable. A full list of rating actions follows at the end of this release.
EWBC: 34.20 (+0.66), BOKF: 61.80 (+0.68), UMBF: 54.21 (+0.75), SNV: 28.98 (+0.42), CATY: 29.12 (+0.42), TCB: 12.53 (+0.09), TRMK: 25.16 (+0.47), FULT: 13.74 (+0.25), BKU: 30.87 (+0.51), FHN: 13.98 (+0.19)

Fitch Affirms TCF Financial at 'BBB-' Following Midtier Regional Bank Review; Outlook Stable
BusinessWire - Thu Jan 28, 1:58PM CST
Fitch Ratings has affirmed TCF Financial Corp.'s (TCB) ratings at 'BBB-/F3'. The Rating Outlook remains Stable.
EWBC: 34.20 (+0.66), BOKF: 61.80 (+0.68), UMBF: 54.21 (+0.75), SNV: 28.98 (+0.42), CATY: 29.12 (+0.42), TCB: 12.53 (+0.09), TRMK: 25.16 (+0.47), FULT: 13.74 (+0.25), BKU: 30.87 (+0.51), FHN: 13.98 (+0.19)

Fitch Affirms Cathay at 'BB+'; Outlook Revised to Positive
BusinessWire - Thu Jan 28, 1:53PM CST
Fitch Ratings has affirmed Cathay General Bancorp's (CATY) and its principal subsidiary Cathay Bank's long-term Issuer Default Ratings (IDRs) at 'BB+' and Viability Ratings (VRs) at 'bb+'. The Rating Outlook has been revised to Positive from Stable. A full list of rating actions is at the end of this press release.
EWBC: 34.20 (+0.66), BOKF: 61.80 (+0.68), UMBF: 54.21 (+0.75), SNV: 28.98 (+0.42), CATY: 29.12 (+0.42), TCB: 12.53 (+0.09), TRMK: 25.16 (+0.47), FULT: 13.74 (+0.25), BKU: 30.87 (+0.51), FHN: 13.98 (+0.19)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading